Centre to consult industry on ₹6,500-crore pharma incentive plan
The Hindu- Business Line 12 June 2020 Maitri Porecha Central Drugs Standard Control Organisation (CDSCO) is set to hold a meeting with all associations of pharmaceutical manufacturers in connection to nearly ₹ 6,500 crores that the centre is planning to dole out as incentives for local production of drug raw materials to domestic producers. The meeting is slated to occur in three phases on June 13 over video conference to discuss draft guidelines of the production linked incentive (PLI) scheme. The PLI scheme is being floated for promotion of domestic key starting materials, drug intermediaries and active pharmaceutical ingredients for antibiotics, steroids, anti-tuberculosis (TB) and diabetic medication amongst others identified as critical for manufacturing in India. For 20 years now, India has been importing KSMs and APIs crucial for drug manufacturing from China. For instance, Penicillin is a key raw material made by fermentation technolo...